Stock Analysis

Hangzhou IECHO Science&Technology Co., Ltd.'s (SHSE:688092) Price Is Right But Growth Is Lacking

Published
SHSE:688092

When close to half the companies in China have price-to-earnings ratios (or "P/E's") above 27x, you may consider Hangzhou IECHO Science&Technology Co., Ltd. (SHSE:688092) as an attractive investment with its 18.8x P/E ratio. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the reduced P/E.

Hangzhou IECHO Science&Technology certainly has been doing a great job lately as it's been growing earnings at a really rapid pace. One possibility is that the P/E is low because investors think this strong earnings growth might actually underperform the broader market in the near future. If you like the company, you'd be hoping this isn't the case so that you could potentially pick up some stock while it's out of favour.

View our latest analysis for Hangzhou IECHO Science&Technology

SHSE:688092 Price to Earnings Ratio vs Industry August 30th 2024
We don't have analyst forecasts, but you can see how recent trends are setting up the company for the future by checking out our free report on Hangzhou IECHO Science&Technology's earnings, revenue and cash flow.

Is There Any Growth For Hangzhou IECHO Science&Technology?

The only time you'd be truly comfortable seeing a P/E as low as Hangzhou IECHO Science&Technology's is when the company's growth is on track to lag the market.

Retrospectively, the last year delivered an exceptional 80% gain to the company's bottom line. As a result, it also grew EPS by 22% in total over the last three years. So we can start by confirming that the company has actually done a good job of growing earnings over that time.

Weighing that recent medium-term earnings trajectory against the broader market's one-year forecast for expansion of 37% shows it's noticeably less attractive on an annualised basis.

With this information, we can see why Hangzhou IECHO Science&Technology is trading at a P/E lower than the market. Apparently many shareholders weren't comfortable holding on to something they believe will continue to trail the bourse.

The Final Word

It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

We've established that Hangzhou IECHO Science&Technology maintains its low P/E on the weakness of its recent three-year growth being lower than the wider market forecast, as expected. Right now shareholders are accepting the low P/E as they concede future earnings probably won't provide any pleasant surprises. If recent medium-term earnings trends continue, it's hard to see the share price rising strongly in the near future under these circumstances.

It's always necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Hangzhou IECHO Science&Technology, and understanding should be part of your investment process.

If you're unsure about the strength of Hangzhou IECHO Science&Technology's business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.

Valuation is complex, but we're here to simplify it.

Discover if Hangzhou IECHO Science&Technology might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.